Trexquant Investment’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $4.48M | Sell |
|
|||||
|
2024
Q4 | $7.67M | Sell |
|
|||||
|
2024
Q3 | $11.4M | Buy |
|
|||||
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $5.23M | Sell |
|
|||||
|
2023
Q4 | $11.6M | Buy |
|
|||||
|
2023
Q3 | $677K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $5.95M | Buy |
|
|||||
|
2022
Q4 | $6.66M | Buy |
|
|||||
|
2022
Q3 | $620K | Buy |
|
|||||
|
2022
Q1 | – | Sell |
|
|||||
|
2021
Q4 | $2.1M | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $807K | Buy |
|
|||||
|
2021
Q1 | – | Sell |
|
|||||
|
2020
Q4 | $698K | Sell |
|
|||||
|
2020
Q3 | $2.57M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $5.46M | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $1.49M | Sell |
|
|||||
|
2019
Q1 | $1.89M | Buy |
|
|||||
|
2018
Q4 | – | Sell |
|
|||||
|
2018
Q3 | $2.09M | Buy |
|
|||||
|
2018
Q2 | – | Sell |
|
|||||
|
2018
Q1 | $2.58M | Buy |
|
|||||
|
2017
Q4 | $233K | Sell |
|
|||||
|
2017
Q3 | $246K | Buy |
|
|||||
|
2017
Q1 | – | Sell |
|
|||||
|
2016
Q4 | $1.55M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.42M | Sell |
|
|||||
|
2015
Q3 | $1.9M | Buy |
|
|||||
|
2015
Q2 | $2.09M | Buy |
|
|||||
|
2015
Q1 | – | Sell |
|
|||||
|
2014
Q4 | $572K | Buy |
|